Redhill Biopharma | 424B5: Prospectus
Redhill Biopharma | EFFECT: Others
Redhill Biopharma | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Redhill Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)
Redhill Biopharma | 20-F: FY2025 Annual Report
Redhill Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Raday Gilead
Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Tsimchi Ofer
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Scruggs Rick D
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Reed Kenneth
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Raday Gilead
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Mamluk Roni
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Ingber Razi
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Goldberg Guy Joel
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Frish Adi
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Cabilly Shmuel
Redhill Biopharma | 3: Initial statement of beneficial ownership of securities- Ben-Asher Dror
Redhill Biopharma | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]